Raza A - Search Results

1

Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts.

Kode A, Manavalan JS, Mosialou I, Bhagat G, Rathinam CV, Luo N, Khiabanian H, Lee A, Murty VV, Friedman R, Brum A, Park D, Galili N, Mukherjee S, Teruya-Feldstein J, Raza A, Rabadan R, Berman E, Kousteni S. Kode A, et al. Among authors: raza a. Nature. 2014 Feb 13;506(7487):240-4. doi: 10.1038/nature12883. Epub 2014 Jan 15. Nature. 2014. PMID: 24429522 Free PMC article.

2

Translational research in myelodysplastic syndromes.

Raza A, Qawi H, Mehdi M, Mumtaz M, Galili N. Raza A, et al. Rev Clin Exp Hematol. 2004 Dec 1;8(2):E2. Rev Clin Exp Hematol. 2004. PMID: 16027100 Review.

3

Lenalidomide for myelodysplastic syndromes: finally, hope not hype.

Raza A, Galili N. Raza A, et al. Nat Clin Pract Oncol. 2005 Aug;2(8):390-1. doi: 10.1038/ncponc0244. Nat Clin Pract Oncol. 2005. PMID: 16130932 No abstract available.

4

Can molecular profiling of cytogenetic subgroups draw a roadmap for individualizing therapy in myelodysplastic syndromes?

Galili NB, Mehdi M, Mumtaz M, Miron P, Woda B, Al-Homsi S, Westervelt P, Raza A. Galili NB, et al. Among authors: raza a. Future Oncol. 2006 Jun;2(3):407-15. doi: 10.2217/14796694.2.3.407. Future Oncol. 2006. PMID: 16787120 Review.

5

Immunomodulatory drugs in myelodysplastic syndromes.

Galili N, Raza A. Galili N, et al. Among authors: raza a. Expert Opin Investig Drugs. 2006 Jul;15(7):805-13. doi: 10.1517/13543784.15.7.805. Expert Opin Investig Drugs. 2006. PMID: 16787143 Review.

6

Low-dose decitabine and high-risk MDS.

Raza A, Raza FZ, Galili N. Raza A, et al. Among authors: raza fz. Blood. 2006 Dec 15;108(13):4291; author reply 4291-2. doi: 10.1182/blood-2006-08-041145. Blood. 2006. PMID: 17148594 Free article. No abstract available.

7

Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16).

Markus J, Garin MT, Bies J, Galili N, Raza A, Thirman MJ, Le Beau MM, Rowley JD, Liu PP, Wolff L. Markus J, et al. Among authors: raza a. Cancer Res. 2007 Feb 1;67(3):992-1000. doi: 10.1158/0008-5472.CAN-06-2964. Cancer Res. 2007. PMID: 17283131

8

Current treatment options: impact of cytogenetics on the course of myelodysplasia.

Galili N, Cerny J, Raza A. Galili N, et al. Among authors: raza a. Curr Treat Options Oncol. 2007 Apr;8(2):117-28. doi: 10.1007/s11864-007-0017-1. Curr Treat Options Oncol. 2007. PMID: 17634837 Review.

9

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.

Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N, Raza A, Root DE, Attar E, Ellis SR, Golub TR. Ebert BL, et al. Among authors: raza a. Nature. 2008 Jan 17;451(7176):335-9. doi: 10.1038/nature06494. Nature. 2008. PMID: 18202658 Free PMC article.

10

Isolation of specific and biologically active peptides that bind cells from patients with acute myeloid leukemia (AML).

Galili N, Devemy E, Raza A. Galili N, et al. Among authors: raza a. J Hematol Oncol. 2008 Jul 10;1:8. doi: 10.1186/1756-8722-1-8. J Hematol Oncol. 2008. PMID: 18616802 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,799 results

Search Page

Filters